US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery Market Research Reports & Industry Analysis

RSS Feeds

Drug Discovery Industry Research & Market Reports

1  2  3  4    6    8  9  10  
Conference Documentation: Immunogenicity
6/30/2015 | published by: SMI Publishing, Ltd
... the latest updates on the prediction and reduction of immunogenicity, clinical results and interpetations and optimising bioassays. Led by selected case studies from leading drug developement teams, bioanalytical experts, and academics we aim to provide ...  |  read more...
USD 788.78
Pharmaceutical Industry in the United States - Porter’s Five Forces Strategy Analysis
7/1/2015 | published by: Aruvian's R'search
... Organization (IO) economics to derive five forces that determine the competitive intensity and therefore attractiveness of a market. Porter referred to these forces as the microenvironment, to contrast it with the more general term macroenvironment. ...  |  read more...
USD 300
LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists -Pipeline Insights, 2015
7/1/2015 | published by: DelveInsight
... TIM-3 Antagonists & OX40 Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The LAG-3 Antagonists, TIM-3 Antagonists & OX40 Agonists Report helps ...  |  read more...
USD 1,250
Pressure Ulcers Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... line data relating to the clinical trials on Pressure Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Global Age-related Macular Degeneration Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... age-related macular degeneration deals by value •Deals listed by company A-Z, industry sector, stage of development, technology type Age-related Macular Degeneration Partnering 2010-2015 provides understanding and access to the age-related macular degeneration partnering deals and ...  |  read more...
USD 1,495
Global Glaucoma Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The Glaucoma Partnering 2010-2015 provides understanding and access to the glaucoma partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 1,495
Global Retinopathy Partnering 2010-2015
7/1/2015 | published by: Current Partnering
... listed by company A-Z, industry sector, stage of development, technology type The Retinopathy Partnering 2010-2015 provides understanding and access to the retinopathy partnering deals and agreements entered into by the worlds leading healthcare companies. The ...  |  read more...
USD 1,495
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... information on the therapeutic development for Retinitis Pigmentosa (Retinitis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Irritable Bowel Syndrome - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... information on the therapeutic development for Irritable Bowel Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Refractory Leukemia - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... therapeutic development for Refractory Leukemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Hepatitis A - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... therapeutic development for Hepatitis A, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Systemic Mastocytosis - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... therapeutic development for Systemic Mastocytosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Gingivitis - Pipeline Review, H1 2015
6/17/2015 | published by: Global Markets Direct
... Gingivitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Renal Cell Carcinoma - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... information on the therapeutic development for Renal Cell Carcinoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Bladder Cancer - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... therapeutic development for Bladder Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutic development for Diffuse Large B-Cell Lymphoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ...  |  read more...
USD 2,000
Small-Cell Lung Cancer - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... information on the therapeutic development for Small-Cell Lung Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Systemic Lupus Erythematosus - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... information on the therapeutic development for Systemic Lupus Erythematosus, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Ischemia Reperfusion Injury - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... information on the therapeutic development for Ischemia Reperfusion Injury, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Migraine - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... Migraine, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Hypercholesterolemia - Pipeline Review, H1 2015
6/24/2015 | published by: Global Markets Direct
... Hypercholesterolemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Vitiligo Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... to the clinical trials on Vitiligo. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
Pompe Disease Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... line data relating to the clinical trials on Pompe Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Epistaxis Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... to the clinical trials on Epistaxis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
Pneumonia Global Clinical Trials Review, H1, 2015
6/16/2015 | published by: GlobalData
... to the clinical trials on Pneumonia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
1  2  3  4    6    8  9  10